Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Wharton

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
The Lancet. Respiratory Medicine|June 19, 2017
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort studyChristopher J Rhodes, John Wharton, Pavandeep Ghataorhe, et al.
Circulation. Cardiovascular Genetics|November 6, 2014
α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlandersMartin R Wilkins, Almaz A Aldashev, John Wharton, et al.
Circulation. Cardiovascular Imaging|October 26, 2018
3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient LungAli Ashek, Onno A Spruijt, Hendrik J Harms, et al.
Circulation|February 8, 2014
Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertensionBeata Wojciak-Stothard, Vahitha B Abdul-Salam, Ka Hou Lao, et al.
The European Respiratory Journal|November 21, 2019
Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertensionAnna Ulrich, John Wharton, Timothy E Thayer, et al.
Pulmonary Circulation|May 11, 2013
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertensionLuke S G E Howard, Geoffrey M J Watson, John Wharton, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2024
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary EmbolismJames Liley, Michael Newnham, Marta Bleda, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
Communications Biology|August 25, 2021
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
The Lancet. Respiratory Medicine|June 19, 2017
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort studyChristopher J Rhodes, John Wharton, Pavandeep Ghataorhe, et al.
Circulation. Cardiovascular Genetics|November 6, 2014
α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlandersMartin R Wilkins, Almaz A Aldashev, John Wharton, et al.
Circulation. Cardiovascular Imaging|October 26, 2018
3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient LungAli Ashek, Onno A Spruijt, Hendrik J Harms, et al.
Circulation|February 8, 2014
Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertensionBeata Wojciak-Stothard, Vahitha B Abdul-Salam, Ka Hou Lao, et al.
The European Respiratory Journal|November 21, 2019
Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertensionAnna Ulrich, John Wharton, Timothy E Thayer, et al.
Pulmonary Circulation|May 11, 2013
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertensionLuke S G E Howard, Geoffrey M J Watson, John Wharton, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2024
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary EmbolismJames Liley, Michael Newnham, Marta Bleda, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
Communications Biology|August 25, 2021
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, et al.
Pageof 7